Baofeng Yang Selected Research

Cardiotoxicity

1/2018	Downregulation of Long Non-Coding RNA Kcnq1ot1: An Important Mechanism of Arsenic Trioxide-Induced Long QT Syndrome.
9/2016	Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis.
9/2013	Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling.
1/2013	Arsenic trioxide-induced hERG K(+) channel deficiency can be rescued by matrine and oxymatrine through up-regulating transcription factor Sp1 expression.
5/2008	Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: implications in cardiotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Baofeng Yang Research Topics

Disease

23	Myocardial Infarction 07/2022 - 09/2009
21	Neoplasms (Cancer) 07/2022 - 09/2002
19	Fibrosis (Cirrhosis) 01/2022 - 01/2007
14	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 01/2008
13	Ischemia 04/2020 - 01/2005
12	Cardiomegaly (Heart Hypertrophy) 01/2022 - 07/2008
12	Cardiac Arrhythmias (Arrythmia) 01/2021 - 09/2002
10	Hypertrophy 01/2022 - 07/2008
10	Atrial Fibrillation 12/2021 - 01/2007
10	Infarction (Infarctions) 01/2021 - 01/2010
9	Hypoxia (Hypoxemia) 12/2021 - 01/2010
8	Heart Failure 01/2022 - 01/2007
8	Acute Promyelocytic Leukemia 01/2018 - 11/2003
7	Heart Diseases (Heart Disease) 01/2021 - 01/2011
6	Wounds and Injuries (Trauma) 12/2020 - 01/2005
6	Myocardial Ischemia (Ischemic Heart Diseases) 04/2020 - 02/2004
5	Pathologic Processes 12/2021 - 01/2010
5	Long QT Syndrome 01/2018 - 04/2007
5	Cardiotoxicity 01/2018 - 05/2008
4	Atherosclerosis 02/2022 - 03/2015
4	Neoplasm Metastasis (Metastasis) 06/2021 - 07/2005
4	Inflammation (Inflammations) 01/2021 - 06/2014
4	Diabetes Mellitus 01/2020 - 06/2009
4	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018 - 11/2009
3	Atherosclerotic Plaque (Atheroma) 02/2022 - 01/2018
3	Body Weight (Weight, Body) 01/2022 - 01/2021
3	Diabetic Cardiomyopathies 12/2021 - 01/2007
3	Infections 12/2021 - 04/2009
3	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 09/2008
3	Reperfusion Injury 01/2021 - 11/2007
3	Type 2 Diabetes Mellitus (MODY) 04/2020 - 11/2018
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 09/2006
3	Hyperglycemia 06/2019 - 03/2003
3	Atrial Remodeling 09/2013 - 01/2011
2	Carcinogenesis 01/2022 - 04/2007
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 08/2020
2	Hypertension (High Blood Pressure) 10/2020 - 12/2016
2	COVID-19 10/2020 - 10/2020
2	Squamous Cell Carcinoma of Head and Neck 11/2019 - 11/2008

Drug/Important Bio-Agent (IBA)

23	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2007
22	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2006
12	Arsenic Trioxide (Trisenox)FDA Link 07/2022 - 11/2003
10	Long Noncoding RNAIBA 01/2022 - 01/2017
9	Pharmaceutical PreparationsIBA 07/2022 - 01/2005
9	CollagenIBA 02/2022 - 08/2009
7	LipidsIBA 02/2022 - 02/2010
7	Ether (Diethyl Ether)IBA 10/2012 - 09/2002
6	Angiotensin IIIBA 12/2021 - 07/2008
6	CalciumIBA 01/2020 - 01/2010
6	Small Interfering RNA (siRNA)IBA 11/2018 - 11/2008
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2003
5	CalcineurinIBA 01/2022 - 04/2011
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2010
4	Biological ProductsIBA 08/2016 - 03/2009
4	Caspase 3 (Caspase-3)IBA 07/2014 - 05/2008
3	Capsules (Microcapsules)IBA 07/2022 - 08/2009
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 03/2003
3	Messenger RNA (mRNA)IBA 01/2022 - 04/2007
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 12/2021 - 04/2011
3	Peptides (Polypeptides)IBA 06/2021 - 01/2018
3	Blood Glucose (Blood Sugar)IBA 11/2020 - 06/2019
3	SodiumIBA 10/2020 - 02/2009
3	Emodin (Archin)IBA 08/2020 - 06/2019
3	Therapeutic UsesIBA 08/2019 - 09/2008
3	Nicotine FDA Link 01/2018 - 08/2009
3	transcription factor NF-AT c3IBA 12/2015 - 04/2011
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2015 - 11/2008
3	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2014 - 10/2011
3	ArsenicIBA 09/2013 - 11/2003
3	Aligeron (AS 2)IBA 01/2013 - 11/2003
3	HomocysteineIBA 09/2012 - 05/2007
3	Calcium-Sensing ReceptorsIBA 02/2012 - 05/2010
3	tanshinoneIBA 04/2011 - 11/2009
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2011 - 01/2005
3	Choline (Choline Chloride)IBA 03/2010 - 01/2005
3	Connexin 43 (Connexin43)IBA 01/2010 - 01/2006
2	Apolipoproteins E (ApoE)IBA 02/2022 - 01/2018
2	ChloridesIBA 01/2022 - 03/2003
2	Superoxide DismutaseIBA 01/2022 - 03/2003
2	Miat long non-coding RNAIBA 12/2021 - 01/2017
2	EndostatinsIBA 06/2021 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 03/2003
2	Competitive Endogenous RNAIBA 01/2021 - 01/2018
2	fibroblast growth factor 21IBA 01/2021 - 01/2020
2	Ouabain (G Strophanthin)IBA 01/2021 - 02/2006
2	InflammasomesIBA 01/2021 - 10/2020
2	Transcription Factors (Transcription Factor)IBA 10/2020 - 09/2002
2	PotassiumIBA 10/2020 - 05/2013
2	riamilovirIBA 10/2020 - 10/2020
2	Indicators and Reagents (Reagents)IBA 08/2020 - 01/2018
2	Anthocyanins (Anthocyanin)IBA 01/2020 - 12/2019
2	Potassium Channels (Potassium Channel)IBA 01/2020 - 10/2012
2	Streptozocin (Streptozotocin)FDA Link 01/2020 - 08/2009
2	IntegrinsIBA 11/2019 - 01/2018
2	PEP06 polypeptideIBA 11/2019 - 01/2018

Therapy/Procedure

13	Therapeutics 12/2021 - 09/2002
5	Ligation 01/2021 - 02/2006
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2013 - 09/2009
2	Low-Level Light Therapy (LLLT) 01/2022 - 01/2021